Charles Elliott Sigal

VIR

Charles Elliott Sigal serves as Director at Vir Biotechnology, Inc. (VIR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$246.3K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$246.3K

Companies Traded

VIR

Active Period

Jan 2023 – Mar 2023

3 total trades

Most Recent

Buy VIR

Mar 2, 2023 · $56.8K

Charles Elliott Sigal's Insider Trading at Vir Biotechnology, Inc. (VIR)

Buys

3 · $246.3K

Sells

0 · $0.00

Total Shares Bought

10,000

Total Shares Sold

VIR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 2, 2023↗	Buy	2,500	$22.73	$56.8K	10,000
Jan 9, 2023↗	Buy	2,500	$24.96	$62.4K	7,500
Jan 5, 2023↗	Buy	5,000	$25.43	$127.1K	5,000

Related Insiders

SATO VICKI L

director

VIRSell · Mar 3, 2026

Mark Eisner

officer: EVP and Chief Medical Officer

VIRSell · Feb 26, 2026

Backer Marianne De

director, officer: Chief Executive Officer

VIRSell · Feb 26, 2026

Mark Eisner

VIRSell · Feb 24, 2026

Jason O'Byrne

CFO

VIRSell · Feb 24, 2026

Backer Marianne De

CEO

VIRSell · Feb 24, 2026

Verneuil Vanina de

General Counsel

VIRSell · Feb 24, 2026

Brent Sabatini

Principal Accounting Officer

VIRSell · Feb 24, 2026

Explore More Insider Trading Data

VIR Insider Trading Activity

View all insider trades at Vir Biotechnology, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity